PAR-25-415: Support for Research Excellence (SuRE-First) Award (R16)

PAR-25-415: Support for Research Excellence (SuRE-First) Award (R16)

The SuRE-First opportunity is an NIH NIGMS funding stream for first independent grants at resource-limited U.S. institutions. It is specifically designed to do two things at once: support early independent biomedical research and strengthen local institutional research culture through student-facing work. This is not a generic startup award for all early-career investigators. It is institution-linked, student-focused, and anchored on helping institutions that historically receive little NIH R01/RPG funding build a stable research environment.

This page is written for researchers, grants offices, and deans looking for a practical path through this NOFO in the 2026/2027 cycle.

Quick reference: key details

What SuRE-First is, and what it is not

SuRE-First sits inside the broader SuRE program structure as the first independent research option for investigators who have not yet secured independent external funding as PI. The NOFO says applicants must commit to projects in basic, social, clinical, behavioral, or translational biomedical science with clear student involvement. The intent is to connect grant support with capacity outcomes, not just short-term project outputs.

What makes this distinct from many NIH opportunities:

• It directly ties applicant and institution criteria to historical low NIH funding and student inclusion indicators.
• The program does not simply fund a proposal; it expects institutions to document an internal plan for research growth.
• It blocks broad use by already-funded independent investigators.
• It excludes most forms of clinical-trial work by default.

This means an applicant with a strong single-PI idea but no institutional alignment, or one at a well-funded research university with established NIH portfolios, usually has weaker fit than intended for this NOFO.

Why this fits the 2026/2027 cycle

The NOFO is currently active with multiple dated NIH submission cycles and a clearly documented deadline list. For a practical planning view, there is a due date in 2026 that is still upcoming and relevant to teams preparing submissions now. The page lists Sept 28, 2026 as a due date, and the announcement also carries additional cycles across later dates and into 2027. In practical terms:

1. This is an active cycle, not an expired-only record.
2. The date structure allows staggered planning depending on internal readiness.
3. Institutions with slower internal approvals can use the earlier deadlines as a rehearsal if they need extra time.

The NOFO also includes a final expiration date in 2028, signaling the mechanism remains available while periodic intake windows continue. For teams prioritizing stable 2026/2027 planning, this is a valid target so long as your registrations and application materials are in place early enough for the selected due date.

Who is eligible and why your application may be rejected immediately

There are two layers of eligibility: institution and investigator.

Institution layer

The opportunity is open to public/private higher-education institutions in the United States that satisfy these conditions:

• award undergraduate and/or graduate biomedical science degrees;
• average no more than $6M NIH RPG total-cost funding each year across the two preceding fiscal years;
• at least 25% of undergraduates supported by Pell grants in either IPEDS measure.

These are institution-level constraints and are non-negotiable. If your institution does not meet these, the application is likely not eligible regardless of proposal quality.

Investigator layer

Applicant PD/PIs must be full-time, independent faculty (e.g., tenure-track or equivalent independent faculty role) and not in postdoctoral or trainee status. The NOFO also limits PI background by requiring that they have not been a PI on NIH SCORE or any peer-reviewed externally funded research grant at submission time. Co-PI structures are limited: SuRE-First is built as a single-PI mechanism.

The NOFO is therefore strongest for institutions that can demonstrate faculty transition into independent research status and can support a PI-centric program structure with student participation.

Eligibility details you should verify before writing a grant narrative

Before drafting sections, verify all of these in one place with your grants office:

• Registration status for SAM/UEI, eRA Commons, and Grants.gov.
• whether institution-level IPF numbers are set and current.
• whether all required institutional and PI profiles are correctly linked.
• whether the institution currently qualifies as SuRE-eligible using the two-year funding and Pell thresholds.
• whether your institution can provide a senior letter and a credible institutional support package.
• whether your PI can commit minimum time in research effort (the NOFO specifies minimum effort expectations).

A key lesson from the NOFO is that missing registrations are not a late submission excuse. NIH flags this repeatedly as a submission risk. If registration takes six weeks or more, start immediately.

Funding mechanics and what “up to $125,000” really means

The announcement allows applications to request up to $125,000 in direct costs per year, excluding F&A, and can support awards for up to four years. The page also states that the number of awards is tied to appropriations and the quality and volume of meritorious applications. This gives two planning lessons:

• do not build an unrealistic budget just to appear larger than peers;
• do not understate effort and infrastructure needs in the name of caution.

A good budget should be directly tied to the proposed scope. Because review considers rigor and feasibility, an aggressive but unrealistic budget can hurt feasibility scoring as much as an undersized plan.

Also note: no foreign institutions are eligible, so international teams need to partner through eligible U.S. institutions with full compliance pathways.

Application process and required submission architecture

The NOFO requires electronic submission only. Paper is not accepted.

Submission route

Use one of the NIH-supported routes:

• NIH ASSIST
• institutional S2S system-to-system solution
• Grants.gov Workspace

Regardless of route, NIH-style SF424(R&R) compliance and NIH’s general submission guide still governs core assembly.

Required content beyond standard NIH forms

The NOFO explicitly lists several extra materials and form practices. Among the highest-impact requirements:

• institutional strategic plan letter on research capacity and excellence;
• institutional support letter focused on the PD/PI’s development;
• PD/PI research enhancement plan;
• prior/pending/current support list.

Missing any of these can make the application incomplete and lead to withdrawal without review. That is not an exaggeration; the NOFO states this in clear terms.

Compliance reminders that often fail applications

• keep submissions compliant with page-limit instructions and attachments guidance;
• include valid PI eRA Commons credentials on forms.
• ensure the UEI and eRA profile identifiers match across required systems.
• avoid clinical trial framing; it is disallowed for this NOFO.

Because this is an NIH opportunity with many moving parts, internal offices often benefit from a one-page pre-flight matrix mapping each requirement to where it sits in the application package.

Review criteria and how NIH reviewers will judge your proposal

The NOFO review structure applies standard NIH peer-review logic but targets three decision domains:

• research importance and innovation;
• rigor and feasibility;
• investigator and environment quality.

Review is not based only on novelty. Reviewers explicitly assess student involvement quality, the likelihood of meaningful research output, and whether the project strengthens institutional capacity. If your narrative focuses only on research outcomes and omits student roles, it loses a core design signal of SuRE-First.

A competitive proposal should show:

• why the scientific question matters within current biomedical priorities;
• a study design that is methodologically robust, reproducible, and realistic;
• direct evidence that the PI has realistic control over the environment and student pipeline;
• explicit milestones that can be reached within the requested period.

Because applications are evaluated for completeness and compliance first, even strong science can be disqualified before scoring if required materials, registrations, or forms are not correct.

Practical application strategy for 2026/2027 deadlines

Use a date-driven planning model. A good strategy is:

1. Backcast from the selected due date (for example Sept 28, 2026)

   • close 6 weeks before: internal draft complete.
   • close 3 weeks before: institutional letters and signatures collected.
   • close 2 weeks before: registrations confirmed, forms check, peer edit.
   • close 1 week before: final validation and pre-submission checks.

2. Build a student-engagement section early The NOFO is explicit that students should participate in meaningful research roles. Draft this as a separate subsection in the Research Plan and budget narrative.

3. Align budget with scope and timeline Use direct costs to fund what you will actually do. Tie every major cost to milestones and feasibility constraints.

4. Document institutional commitment The required letters are not ceremonial. They are evidence that the applicant institution is willing to sustain this PI and research trajectory.

5. Run a compliance-only pass before scientific edits Confirm allowed application type (new/resubmission/revision), required fields, and routing path first, then polish narrative.

Common mistakes that derail otherwise strong proposals

Mistake 1: treating eligibility as a formality

Institutional criteria are material. If the institution fails the RPG/pell/degree thresholds, eligibility breaks before review.

Mistake 2: submitting a clinical-trial-style design

Clinical trials are not accepted under this NOFO. If your project would need clinical-trial infrastructure, reframe your scope or choose another opportunity.

Mistake 3: under-specifying student engagement

The program goal is not just individual career development. It explicitly ties project success to student participation and institutional strengthening. Generic training language is usually weaker than a concrete participation plan.

Mistake 4: allowing one missing attachment

All four institution/PI attachment items are mandatory. Even one missing item can produce withdrawal status without review.

Mistake 5: late compliance

NIH registration delays and mismatched IDs are common causes of “not reviewed” outcomes, even for strong concept science. Resolve system registration first, then write.

Who should apply and who should pause

Apply if you match all of the following:

• your institution is intentionally in a lower-funded NIH profile and committed to increasing capacity;
• you are a full-time independent faculty member without prior independent PI grant status;
• you can show meaningful student participation and a realistic environment where students can participate in real hands-on research;
• your internal office can complete registrations early.

Pause and re-scope if:

• you cannot meet institutional thresholds;
• you are already leading NIH SCORE or other independent awards;
• your project is clinical-trial centric;
• your institution cannot secure the mandatory letters in time.

FAQ

What is the funding amount?

The NOFO states applications may request up to $125,000 in direct costs per year, excluding F&A, with awards up to 4 years.

Is this recurring?

The mechanism is not a one-off posting-only opportunity; this NOFO includes multiple cycles with ongoing relevance through 2027 dates and a broader expiration horizon into 2028.

Can a team submit more than once?

An institution can submit more than one application if each is scientifically distinct and led by a different PD/PI. However, a PD/PI cannot submit overlapping applications to SuRE-First and SuRE companion NOFOs at the same time.

Can renewals be submitted?

The NOFO lists application types as new, resubmission, and revision. It explicitly says SuRE-First awards are not renewable.

What if registration is incomplete near the deadline?

The NOFO is clear that failure to complete required registrations is not a valid late submission excuse. Plan registration at least 6 weeks in advance.

Are paper applications accepted?

No. Electronic submission only.

Required links, source documents, and next steps

Use direct official pages only:

• PAR-25-415 official NOFO on grants.nih.gov
• NIH How to Apply Guide
• Grants.gov
• eRA Commons

Before you hit submit, complete a final compliance pass:

1. confirm eligibility criteria are met and documented;
2. verify submission type and due-date choice;
3. validate all required attachments are included;
4. confirm PI credentials and registration identifiers are correct;
5. confirm no clinical-trial design features conflict with funding instructions;
6. run an internal pre-submission technical check.

If those pass, your application should be judged primarily on scientific merit, feasibility, and fit with SuRE-First’s capacity-building intent.